Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: United Kingdom Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20162
20182
20193
20203
20211
20221
20233
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting9
Recruiting6
Terminated6
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Cancer Research UK3
Amgen1
Basilea Pharmaceutica1
BicycleTx Limited1
BioNTech SE1
Genmab1
Kymab Limited1
Merus B.V.1
Nektar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms23
Carcinoma, Non-Small-Cell Lung12
Colorectal Neoplasms8
Esophageal Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Triple Negative Breast Neoplasms8
Melanoma6
Pancreatic Neoplasms6
Neoplasms5
Ovarian Neoplasms5

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.